It's golden autumn, the fragrance of osmanthus is flowing, and the bright moon is in the sky. On October 17, the Nanjing Pharmacare Customer Appreciation Dinner with the theme of “Gather together for win-win cooperation” was held in Nanjing.
We are honored to invite all the guests who have been caring about and helping the growth of Pharmacare to come to the appreciation dinner, and at the same time, we also invited the host of Jiangsu Radio and Television Station to preside over the event, and young singers sang on the same stage. The scene was full of friends and joyful gathering.
Introduction to Pharmacare's main business
The dinner started in a warm atmosphere. First of all, Mr. Xu Chenxi, Assistant General Manager of Nanjing Pharmacare Co., Ltd. and General Manager of Jiangxi Huabang Pharmaceutical Co., Ltd. spoke on the stage, and led us to review the growth history of Pharmacare in the past eight years, the achievements made, and conveyed the corporate culture of Pharmacare. At the same time, Mr. Xu Chenxi introduced the main business sections of Pharmacare to the guests.
Relying on "Regulatory Consulting and Technical Support", the company has formed four main business segments: Pharmaceutical Formulation Export, Pharmaceutical Formulation Regulatory Market, Pharmaceutical API and Intermediates Export and Pharmaceutical API Domestic Marketing.
Pharmaceutical preparations exports, under the company's overall strategy of focusing on products and markets, the company has taken to focus on key projects, plowing into emerging markets and accelerating the layout of the regulatory market.
Pharmaceutical preparations regulatory market, based on the core program, comprehensive layout of the European market. Relying on the flexible and solid business foundation, we help our clients to screen the feasible registration paths and deeply participate in the commercial operation of the target market.
Pharmaceutical APIs and intermediates export, focusing on regulatory and semi-regulatory markets, with customers covering Central and South America, the Middle East, the CIS, Japan and South Korea, Europe and other countries and regions. Products focus on contrast agents, hypoglycemic, anti-tumor, cardiovascular and cerebrovascular areas.
Domestic marketing of pharmaceutical APIs, focusing on APIs with certain technical barriers or avoiding patents, rich in market value, rare diseases, etc. Establishing close strategic cooperative relationships with well-known domestic and foreign API manufacturers.
The four business segments and the regulatory and technical service team constitute a comprehensive business platform from intermediates to APIs to formulations. We provide not only business solutions, but also clinical solutions, registration solutions, and technical solutions, such as quality standard upgrades, CTD file compilation, and advanced technology introduction. The seven-in-one cooperation platform built through years of experience in the market is the embodiment of the "differentiated competitiveness" of Pharmacare, which is different from that of traditional trade.
Speech by the President and General Manager
Mr. Liang Jian, Chairman and General Manager of the company, delivered a speech on the stage, thanking the old friends who have been quietly accompanying and supporting Pharmacare, as well as the new partners who have been acquainted with Pharmacare and have become friends at first sight. Every progress and success of Pharmacare is inseparable from our common wisdom, efforts and collaboration.
From the very beginning of its establishment, Nanjing Pharmacare has been adhering to the concept of "always insisting on the continuous creation of value for our partners", and is committed to creating differentiated core competitiveness, integrating resources, complementing each other's strengths, empowering our partners, creating new value for our partners, and expanding and strengthening the international and domestic markets. At the same time, we always insist on "doing the hard but right thing", focusing on high-barrier products and high-barrier markets. In project cooperation, Pharmacare also adheres to the principle of joint investment and risk sharing with partners, and constantly explores and innovates the business cooperation model, so as to create the future hand in hand.
After the speech, Mr. Liang and all the guests at the scene raised their glasses together and announced the start of the dinner.
Gathering peers for win-win cooperation
Pharmacare will further strengthen the existing business foundation, accelerate the layout of global sales channels, and help the development of Chinese pharmaceutical enterprises.
In the future, we will continue to work together to achieve win-win cooperation.
Grateful to be with you, Farmer Mac has always been there.
Japanese
Chinese
Spanish